Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 5
3,633
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Steady state plasma and tissue distribution of low molecular weight hyaluronic acid after oral administration in mice

, , &
Pages 773-780 | Received 20 Dec 2022, Accepted 27 Mar 2023, Published online: 20 Apr 2023

References

  • Aragona P, Papa V, Micali A, Santocono M, Milazzo G. 2002. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol. 86(2):181–184. PMID: 11815344; PMCID: PMC1771021.
  • Balogh L, Polyak A, Mathe D, Kiraly R, Thuroczy J, Terez M, Janoki G, Ting Y, Bucci LR, Schauss AG. 2008. Absorption, uptake, and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs. J Agric Food Chem. 56(22):10582–10593. PMID: 18959406.
  • Battaglia M, Guaraldi F, Vannini F, Rossi G, Timoncini A, Buda R, Giannini S. 2013. Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics. 36(12):e1501–e1508. PMID: 24579221.
  • Bray BA. 2001. The role of hyaluronan in the pulmonary alveolus. J Theor Biol. 210(1):121–130. PMID: 11343436.
  • Chang E-J, Kim HJ, Ha J, Kim HJ, Ryu J, Park K-H, Kim U-H, Lee ZH, Kim H-M, Fisher DE, et al. 2007. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J Cell Sci. 120(Pt 1):166–176.
  • Ciofalo A, Zambetti G, Altissimi G, Fusconi M, Soldo P, Gelardi M, Iannella G, Pasquariello B, Magliulo G. 2017. Pathological and cytological changes of the nasal mucosa in acute rhinosinusitis: the role of hyaluronic acid as supportive therapy. Eur Rev Med Pharmacol Sci. 21(19):4411–4418. PMID: 29077152.
  • Costantino D, Guaraldi C. 2008. Effectiveness, and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial. Eur Rev Med Pharmacol Sci. 22(6):411–6.
  • Cyphert JM, Trempus CS, Garantziotis S. 2015. Size matters: molecular weight specificity of hyaluronan effects in cell biology. Int J Cell Biol. 2015:563818. Epub 2015 Sep 10. PMID: 26448754; PMCID: PMC4581549.
  • Essendoubi M, Gobinet C, Reynaud R, Angiboust JF, Manfait M, Piot O. 2016. Human skin penetration of hyaluronic acid of different molecular weights as probed by Raman spectroscopy. Skin Res Technol. 22(1):55–62.
  • Fraser JR, Laurent TC, Laurent UB. 1997. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 242(1):27–33. PMID: 9260563.
  • Gao F, Yang CX, Mo W, Liu YW, He YQ. 2008. Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing. Clin Invest Med. 31(3):E106–16.
  • Gariboldi S, Palazzo M, Zanobbio L, Selleri S, Sommariva M, Sfondrini L, Cavicchini S, Balsari A, Rumio C. 2008. Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J Immunol. 181(3):2103–2110.
  • Göllner I, Voss W, von Hehn U, Kammerer S. 2017. Ingestion of an oral hyaluronan solution improves skin hydration, wrinkle reduction, elasticity, and skin roughness: results of a clinical study. J Evid Based Complementary Altern Med. 22(4):816–823. Epub 2017 Dec 4. PMID: 29228816; PMCID: PMC5871318.
  • Gomes JA, Amankwah R, Powell-Richards A, Dua HS. 2004. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol. 88(6):821–825. PMID: 15148219; PMCID: PMC1772195.
  • Heldin P, Lin CY, Kolliopoulos C, Chen YH, Skandalis SS. 2019. Regulation of hyaluronan biosynthesis and clinical impact of excessive hyaluronan production. Matrix Biol. 78–79:100–117. Epub 2018 Jan 31. PMID: 29374576.
  • Hisada N, Satsu H, Mori A, Totsuka M, Kamei J, Nozawa T, Shimizu M. 2008. Low-molecular-weight hyaluronan permeates through human intestinal Caco-2 cell monolayers via the paracellular pathway. Biosci Biotechnol Biochem. 72(4):1111–1114. Epub 2008 Apr 7. PMID: 18391466.
  • Homayun B, Lin X, Choi HJ. 2019. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 11(3):129. PMID: 30893852; PMCID: PMC6471246.
  • Huynh A, Priefer R. 2020. Hyaluronic acid applications in ophthalmology, rheumatology, and dermatology. Carbohydr Res. 489:107950. Epub 2020 Feb 18. PMID: 32070808.
  • Jensen GS, Attridge VL, Lenninger MR, Benson KF. 2015. Oral intake of a liquid high-molecular-weight hyaluronan associated with relief of chronic pain and reduced use of pain medication: results of a randomized, placebo-controlled double-blind pilot study. J Med Food. 18(1):95–101. PMID: 25415767; PMCID: PMC4281855.
  • Jiang D, Liang J, Noble PW. 2011. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 91(1):221–264. PMID: 21248167; PMCID: PMC3051404.
  • Kavasi R-M, Berdiaki A, Spyridaki I, Corsini E, Tsatsakis A, Tzanakakis G, Nikitovic D. 2017. HA metabolism in skin homeostasis and inflammatory disease. Food Chem Toxicol. 101:128–138. Mar
  • Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG. 2010. Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol. 160(7):1577–1579.
  • Kimura M, Maeshima T, Kubota T, Kurihara H, Masuda Y, Nomura Y. 2016. Absorption of orally administered hyaluronan. J Med Food. 19(12):1172–1179. PMID: 27982756.
  • Komatsu S, Iwata H, Nabeshima T. 1999. Studies on the kinetics, metabolism and re-utilisation after intra-articular administration of hyaluronan to rabbits. Arzneimittelforschung. 49(5):427–433.
  • La Galia T, Micali A, Puzzolo D, Cancellieri F. 2014. Oral low-molecular weight hyaluronic acid in the treatment of atrophic vaginitis. Indian J Community Med. 5(11):617–624.
  • Laurent UBG, Dahl LB, Reed RK. 1991. Catabolism of hyaluronan in rabbit skin takes place locally in lymph nodes and liver. Exp Physiol. 76(5):695–703.
  • Leal J, Smyth HDC, Ghosh D. 2017. Physicochemical properties of mucus and their impact on transmucosal drug delivery. Int J Pharm. 532(1):555–572.
  • Lipko-Godlewska S, Bolanča Ž, Kalinová L, Kermen I, Onisak B, Papp I, Rebrov M, Valančienė G. 2021. Whole-face approach with hyaluronic acid fillers. Clin Cosmet Investig Dermatol. 14:169–178. PMID: 33633459; PMCID: PMC7901566.
  • Nakamura K, Yokohama S, Yoneda M, Okamoto S, Tamaki Y, Ito T, Okada M, Aso K, Makino I. 2004. High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice. J Gastroenterol. 39(4):346–354.
  • Nolan A, Baillie C, Badminton J, Rudralingham M, Seymour RA. 2006. The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration. J Oral Pathol Med. 35(8):461–465. PMID: 16918596.
  • Piro F, Marafioti L. 2018. Oral low molecular weight hyaluronic acid in the prevention and treatment of radiation-induced cystitis. IJMDAT. 1(1):e112.
  • Sato T, Sakamoto W, Odanaka W. 2002. Clinical effect of hyaluronic acid diet for dry and rough skin. Aesthetic Dermatol. 12:109–120.
  • Tamer TM. 2013. Hyaluronan and synovial joint: function, distribution, and healing. Interdiscip Toxicol. 6(3):111–125. PMID: 24678248; PMCID: PMC3967437.
  • Valachová K, Šoltés L. 2021. Hyaluronan as a prominent biomolecule with numerous applications in medicine. Int J Mol Sci. 22(13):7077. PMID: 34209222; PMCID: PMC8269271.
  • Vasvani S, Kulkarni P, Rawtani D. 2020. Hyaluronic acid: a review on its biology, aspects of drug delivery, route of administrations and a special emphasis on its approved marketed products and recent clinical studies. Int J Biol Macromol. 151:1012–1029. Epub 2019 Nov 9. PMID: 31715233.